Three antipsychotic drugs that have long been prescribed to adolescents even though they were not approved for such use by the Food and Drug Administration deserve to have the regulatory agency's imprimatur, an FDA advisory committee said yesterday.
After weighing the costs and benefits of prescribing the antipsychotic drugs Seroquel, Geodon and Zyprexa for children 10 to 17 years old who suffer from schizophrenia and manic depression, the medical experts recommended that the drugs be approved for such use.
Read More: FDA Is Urged to Approve Drugs for Adolescent Use
